BAX - Baxter International - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0718131099

Medical Devices, Infusion Systems, Pharmaceuticals, Dialysis Equipment

Baxter International Inc. is a global healthcare company that develops and provides a wide range of medical products and services to patients and healthcare providers worldwide.

The company operates through four main business segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. These segments enable Baxter to offer a diverse portfolio of products, including sterile IV solutions, infusion systems, parenteral nutrition therapies, and generic injectable pharmaceuticals.

Baxter's product portfolio also includes surgical hemostat and sealant products, advanced surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. Additionally, the company provides administrative sets, adhesion prevention products, inhaled anesthesia, and drug compounding solutions.

In the area of kidney care, Baxter offers chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies, and other organ support therapies. These products and services are used in various healthcare settings, such as hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients' homes under physician supervision.

Baxter sells its products through a combination of direct sales force and independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. The company has a global presence, operating in approximately 100 countries worldwide.

Baxter has partnerships with other companies, such as Celerity Pharmaceutical, LLC, to develop acute care generic injectable premix and oncolytic products. The company also has a collaborative research agreement with Miromatrix Medical Inc. to advance care for patients with acute liver failure.

Founded in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois, and is committed to improving healthcare outcomes for patients around the world. For more information, visit the company's website at https://www.baxter.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for BAX - Baxter International  - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for BAX - Baxter International  - Stock & Dividends

BAX Stock Overview

Market Cap in USD 18,182m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1981-10-27

BAX Stock Ratings

Growth 5y -57.0
Fundamental -12.8
Dividend 59.6
Rel. Performance vs Sector -1.48
Analysts 3.50/5
Fair Price Momentum 31.26 USD
Fair Price DCF 36.94 USD

BAX Dividends

Dividend Yield 12m 3.27%
Yield on Cost 5y 1.48%
Dividends CAGR 5y 6.42%
Payout Consistency 94.3%

BAX Growth Ratios

Growth 12m -22.11%
Growth Correlation 12m -10%
Growth Correlation 3m -16%
CAGR 5y -14.61%
CAGR/Mean DD 5y -0.53
Sharpe Ratio 12m -1.01
Alpha vs SP500 12m -34.81
Beta vs SP500 5y weekly 0.47
ValueRay RSI 64.66
Volatility GJR Garch 1y 30.24%
Price / SMA 50 4.01%
Price / SMA 200 -3.79%
Current Volume 3470.5k
Average Volume 20d 5098.3k

External Links for BAX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BAX stocks?
As of July 27, 2024, the stock is trading at USD 35.51 with a total of 3,470,476 shares traded.
Over the past week, the price has changed by +0.45%, over one month by +4.75%, over three months by -10.74% and over the past year by -19.05%.
What are the forecast for BAX stock price target?
According to ValueRays Forecast Model, BAX Baxter International will be worth about 33.8 in July 2025. The stock is currently trading at 35.51. This means that the stock has a potential downside of -4.93%.
Issuer Forecast Upside
Wallstreet Target Price 41.9 18.1
Analysts Target Price 47.1 32.6
ValueRay Target Price 33.8 -4.93